ATMS — Stock Film
STOCK FILMSCENE 1/10ATMS · $0.50
Stock Expert AI presents
ATMS
Artemis Therapeutics Inc
~3 min film100% real numbers0 jargon
WHAT DOES THIS COMPANY DO?
Artemis Therapeutics Inc. A quick introduction.

On the stock market since 1998, it operates in the world of money and finance. It has 4 employees. Now — the numbers.

on the stock market since 1998
4 employees
$55.8M market value
Revenue last year:
$0
The loss that same year:
$0
For every $1 it earns, the company spends $5.

The company is still in the product-building phase: its spending runs far above its sales. That only changes once the product starts selling at scale.

THE SALES TREND
Sales are moving sideways.

No real growth (5% a year). Red columns mark years that ended in a loss.

$259K
2018
$0
2019
$0
2020
$0
2021
$311K
2022
In the vault right now:
$0
DEBT: $356K
At this pace, that money lasts less than a year.

Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.

THE COUNCIL REVIEW
9

angles, checked one by one.

The 2 that stand out are on screen; the rest came back neutral.

The council scores out of 10; report-card grades are out of 100.

WEAK SPOTS
The stock has lost its spark0/10
Costs eat into the margin4/10
WORTH WATCHING

Cost Efficiency: As sales grow, profit fails to keep the same pace.

THE FIVE-YEAR JOURNEY
A big climb, then a hard fall.

An investor who bought at the very peak is down 93% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.

1
THE BRIGHT SIDE · 1/1
The product is selling

Sales run at $311K a year. A small number, but proof the product has real buyers.

1
THE RISKS · 1/3
Small sales, big loss

A loss of $1.4M against $311K in annual sales.

2
THE RISKS · 2/3
Trading under $1

The stock sits at $0.50. Under exchange rules, stocks that stay below $1 for too long risk being removed from the market.

3
THE RISKS · 3/3
The cash has a countdown

At the current pace of spending, the cash lasts less than a year. After that, the company needs to find new money.

FINALE · THE GRADE
C
0 / 100 · MoonshotScore

On our five-subject report card, ATMS sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.

The takeaway: ATMS is a high-risk stock — not yet profitable, and its future rides on its product catching on.

What would you like to do next?
Open the stock page →
This was a film — not investment advice.
Data: FMP & company filings
Jul 24, 2026 · stockexpertai.com · Stock Film